Epigral Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review

Epigral (NSE:EPIGRAL) CMP: Rs 1,148.8 (2026). 52W High: Rs 2,114. 52W Low: Rs 806. MCap: Rs 4,941 Cr. P/E: 15.2. Sector: Specialty Chemicals and Agrochemicals. JM Financial: Neutral Rs 1350. Kotak …

The Epigral stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Epigral share price prediction as one data point and not as a guarantee of future performance.

This article reviews every dimension of the Epigral stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.

Click Here – Get Free Investment Predictions

What Analysts Predict for Epigral Stock in 2026

Analyst consensus on the Epigral stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and Kotak Securities. All figures are sourced from publicly available research and should be verified before publishing.

The analyst target range for Epigral reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Epigral stock forecast from the current price of Rs 1,148.8 may or may not be realised by end of 2026.

Epigral Company Overview

Epigral is a specialty chemicals or agrochemical company serving domestic and global markets. The Epigral stock prediction for 2026 reflects export recovery potential and margin expansion from operating leverage.

Epigral Stock Prediction by Time Horizon

Analysts split the Epigral share price prediction across time frames as near-term drivers differ materially from the long-term view.

Short-Term Epigral Stock Prediction

The near-term Epigral stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 1,148.8 are being watched closely. A short-term Epigral share price prediction carries the most uncertainty of any time horizon.

12-Month Epigral Stock Prediction

JM Financial targets Rs 1350 (Neutral) and Kotak Securities targets Rs 1260 (Neutral). Most desks refresh their Epigral stock forecast within two to four weeks of each quarterly earnings print. The Epigral share price prediction should be verified against the most recent analyst reports.

Long-Term Epigral Stock Prediction

The long-term outlook for Epigral is built on assumptions about demand recovery, margin expansion and revenue diversification in the Specialty Chemicals and Agrochemicals sector. Long-term price targets carry the most uncertainty and should be treated as directional guidance only.

Epigral Stock Forecast: Key Factors

The following four factors appear consistently in analyst research on Epigral and are the primary inputs into the bull and bear case scenarios.

Export Revenue Recovery

A recovery in global chemical demand is the primary catalyst in the Epigral stock forecast. Analysts who set a higher Epigral stock prediction point to export order recovery as their main justification for the Epigral share price prediction.

Capacity Utilisation and Operating Leverage

Rising capacity utilisation from recent capital investment drives operating leverage and margin expansion. Analysts revise the Epigral share price prediction upward when utilisation improves.

Product Mix and Value Addition

A shift toward higher-value specialty products improves realization. Analysts track the specialty-to-commodity revenue ratio in their Epigral share price prediction models.

EBITDA Margin Trajectory

Sustained EBITDA margin is typically the basis for the bullish Epigral stock prediction. Margin recovery is the single most important variable in the Epigral stock forecast from most research desks.

Epigral Stock Prediction: Bull and Bear Scenarios

The bull case Epigral stock forecast of Rs 1350 assumes most positive variables converge. The base case of Rs 1305 is the analyst consensus and may or may not be achieved.

How Analysts Are Reading the Epigral Stock Story

Analyst reviews of the Epigral share price prediction highlight the company’s core strengths in Specialty Chemicals and Agrochemicals alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the analyst consensus for Epigral is built on real business strengths set against real risks.

Key Risks to the Epigral Stock Prediction

China Competition

Chinese producers compete aggressively on price. Dumping risk and China’s overcapacity are structural headwinds to the Epigral stock prediction reflected in the cautious Epigral share price prediction.

Raw Material Cost Volatility

Petrochemical feedstocks see frequent price swings. Sustained input cost increases compress margins and force downward revisions to the Epigral stock forecast.

Export Demand Weakness

Global industrial demand weakness or inventory destocking by key export customers directly affects volumes and the Epigral share price prediction.

Regulatory and Environmental Risk

Increasing environmental and safety regulations affect compliance costs and are recurring risks to the Epigral share price prediction.

How to Monitor the Epigral Stock Forecast

Track the Epigral share price prediction consensus quarterly. After every earnings release, most brokerages revise their Epigral stock forecast within two weeks. Comparing the revised analyst target to the previous estimate tells you whether sentiment on Epigral is improving or deteriorating.

Compare the current price of Rs 1,148.8 with the analyst target range of Rs 1350 to Rs 1260. A wide target band reflects genuine uncertainty on Epigral, so position size should reflect that range rather than the midpoint alone.

Review the Epigral share price prediction every quarter against key business metrics for the Specialty Chemicals and Agrochemicals sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.

Check Live Epigral Fundamentals on the Univest Screener

Conclusion

The Epigral stock prediction for 2026 reflects the analyst community’s assessment of Epigral’s competitive position, earnings trajectory and macro environment. JM Financial holds a Neutral stance with a target of Rs 1350 while Kotak Securities has a Neutral rating with a target of Rs 1260, giving an analyst consensus of Rs 1305.

The Epigral stock forecast is set against near-term risks that make the Epigral share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking how the Epigral share price target changes over time is more valuable than relying on any single estimate.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Download the Univest iOS App or Univest Android App to track live analyst targets, price movements and research updates for Epigral in real time.

Frequently Asked Questions on Epigral Stock Prediction 2026

What is the Epigral stock prediction for 2026?

Ans. The Epigral stock prediction for 2026 is based on analyst consensus from JM Financial and Kotak Securities. The consensus target is Rs 1305. All estimates may or may not be achieved.

Is the Epigral stock prediction bullish or bearish?

Ans. JM Financial has a Neutral rating with target Rs 1350. Kotak Securities has a Neutral rating with target Rs 1260. The Epigral stock forecast reflects genuine analyst diversity of opinion.

What is the Epigral share price prediction based on fundamentals?

Ans. The Epigral share price prediction rests on the export order recovery, margin trajectory, China competition dynamics and capacity utilisation. Analysts tracking Epigral closely cite these as the primary drivers of the 2026 outlook.

What is the long-term Epigral stock prediction?

Ans. The long-term outlook assumes Epigral sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 1305 is the nearest reliable anchor point.

What are the key risks to the Epigral stock prediction?

Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for Epigral should be read alongside its risk assumptions.

What does the Epigral stock forecast say for 2026?

Ans. JM Financial: Neutral target Rs 1350. Kotak Securities: Neutral target Rs 1260. These Epigral share price prediction estimates may or may not prove accurate.

Where can I track the latest Epigral stock prediction?

Ans. Track the latest analyst targets and price movements for Epigral on the NSE and BSE websites and on the Univest app and screener for live data.